Brief: India's Caplin Point Laboratories March-Qtr Consol Net Profit Rises
May 6 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* MARCH-QUARTER CONSOL NET PROFIT 663.7 MILLION RUPEES
VERSUS
488.9 MILLION RUPEES YEAR AGO
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 2.79 BILLION
RUPEES
VERSUS 2.15 BILLION RUPEES YEAR AGO
* DECLARED INTERIM DIVIDEND OF 1.50 RUPEES/SHARE
* COMPANY TARGETS US FRONT END PRESENCE IN 2023
Source text: https://bityl.co/6i5A
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees